Concept information
Preferred term
Xamoterol
Type
-
mesh:Descriptor
Definition
- A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.
Broader concept
Entry terms
- 112008-18-1
- 112008-19-2
- 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-
- 69630-22-4
- 7HE0JQL703
- 81801-12-9 (Xamoterol)
- 90730-93-1 (Xamoterol Fumarate)
- N87007N668
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
112008-18-1
-
112008-19-2
-
4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-
-
69630-22-4
-
7HE0JQL703
-
81801-12-9 (Xamoterol)
-
90730-93-1 (Xamoterol Fumarate)
-
N87007N668
URI
http://data.loterre.fr/ark:/67375/JVR-BRKBQW48-1
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}